Summary:
- The article discusses a new study that found people with Alzheimer's disease may have higher levels of certain proteins in their blood compared to people without the disease.
- The study analyzed blood samples from over 2,000 people and identified two specific proteins, neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP), that were elevated in individuals with Alzheimer's.
- The findings suggest these blood-based biomarkers could potentially be used to help diagnose Alzheimer's disease and monitor its progression, which could lead to earlier interventions and improved patient care.